Lisa M. Stuart

921 total citations
17 papers, 618 citations indexed

About

Lisa M. Stuart is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lisa M. Stuart has authored 17 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Lisa M. Stuart's work include MicroRNA in disease regulation (4 papers), Phagocytosis and Immune Regulation (3 papers) and Cancer Mechanisms and Therapy (2 papers). Lisa M. Stuart is often cited by papers focused on MicroRNA in disease regulation (4 papers), Phagocytosis and Immune Regulation (3 papers) and Cancer Mechanisms and Therapy (2 papers). Lisa M. Stuart collaborates with scholars based in Australia, United States and Singapore. Lisa M. Stuart's co-authors include Peter J. Leedman, Michael R. Epis, Patrick A. Candy, Felicity C. Kalinowski, Keith M. Giles, Andrew Redfern, Kirsty Richardson, Dianne J. Beveridge, Rikki A. M. Brown and Gregory J. Goodall and has published in prestigious journals such as Molecular Cell, Hepatology and Cancer Research.

In The Last Decade

Lisa M. Stuart

14 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa M. Stuart Australia 12 363 219 133 127 50 17 618
Cheng Zeng China 15 401 1.1× 230 1.1× 101 0.8× 132 1.0× 46 0.9× 39 745
Pengyun Qiao China 17 436 1.2× 252 1.2× 137 1.0× 153 1.2× 79 1.6× 23 779
Yajun Liang China 10 322 0.9× 183 0.8× 59 0.4× 185 1.5× 47 0.9× 13 524
Yueting Shao China 14 317 0.9× 158 0.7× 97 0.7× 203 1.6× 65 1.3× 26 616
Chian‐Feng Chen Taiwan 18 533 1.5× 240 1.1× 56 0.4× 150 1.2× 40 0.8× 32 830
Shawn Pan United States 5 307 0.8× 167 0.8× 53 0.4× 160 1.3× 17 0.3× 8 553
Luying Li China 15 234 0.6× 111 0.5× 170 1.3× 116 0.9× 29 0.6× 35 614
Silvia Viaggi Italy 15 366 1.0× 271 1.2× 73 0.5× 134 1.1× 36 0.7× 35 664
Richard Larson United States 16 422 1.2× 275 1.3× 132 1.0× 309 2.4× 32 0.6× 27 846
Chung‐Hsing Chen Taiwan 17 551 1.5× 224 1.0× 194 1.5× 171 1.3× 29 0.6× 35 886

Countries citing papers authored by Lisa M. Stuart

Since Specialization
Citations

This map shows the geographic impact of Lisa M. Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Stuart more than expected).

Fields of papers citing papers by Lisa M. Stuart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Stuart. The network helps show where Lisa M. Stuart may publish in the future.

Co-authorship network of co-authors of Lisa M. Stuart

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Stuart. A scholar is included among the top collaborators of Lisa M. Stuart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Stuart. Lisa M. Stuart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Beveridge, Dianne J., Andrew J. Woo, Kirsty Richardson, et al.. (2025). PACT is requisite for prostate cancer cell proliferation. Scientific Reports. 15(1). 36610–36610.
2.
Kabir, Tasnuva D., Samuel J. Beck, Lisa M. Stuart, et al.. (2025). Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma. Cell Death and Disease. 16(1). 561–561. 1 indexed citations
3.
Mahboobnia, Khadijeh, Tasnuva D. Kabir, Rui Hou, et al.. (2025). MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1. International Journal of Molecular Sciences. 26(9). 4161–4161.
4.
Kim, Mijeong, Bum‐Kyu Lee, Kirsty Richardson, et al.. (2022). A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer. Oncogenesis. 11(1). 60–60. 9 indexed citations
5.
Beveridge, Dianne J., Kirsty Richardson, Michael R. Epis, et al.. (2021). The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. Scientific Reports. 11(1). 18003–18003. 18 indexed citations
6.
Beveridge, Dianne J., Tasnuva D. Kabir, Andrew J. Woo, et al.. (2021). Abstract 2379: microRNA-7 replacement therapy: a promising approach for hepatocellular carcinoma. Cancer Research. 81(13_Supplement). 2379–2379.
7.
Brown, Rikki A. M., Kirsty Richardson, Felicity C. Kalinowski, et al.. (2017). Evaluation of MicroRNA Delivery In Vivo. Methods in molecular biology. 1699. 155–178. 15 indexed citations
8.
Epis, Michael R., Keith M. Giles, Dianne J. Beveridge, et al.. (2017). miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression. Oncotarget. 8(33). 55116–55134. 20 indexed citations
9.
Kabir, Tasnuva D., Clarissa Ganda, Rikki A. M. Brown, et al.. (2017). A microRNA‐7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib‐resistant cells in human hepatocellular carcinoma. Hepatology. 67(1). 216–231. 107 indexed citations
10.
Rudnicka, Caroline, Satsuki Mochizuki, Yasunori Okada, et al.. (2016). Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer. Medicine. 95(40). e5085–e5085. 16 indexed citations
11.
Giles, Keith M., Rikki A. M. Brown, Clarissa Ganda, et al.. (2016). microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB. Oncotarget. 7(22). 31663–31680. 65 indexed citations
12.
Giles, Keith M., Felicity C. Kalinowski, Patrick A. Candy, et al.. (2013). Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib. Molecular Cancer Therapeutics. 12(11). 2541–2558. 122 indexed citations
13.
Candy, Patrick A., Michael Phillips, Andrew Redfern, et al.. (2013). Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients. British Journal of Cancer. 109(4). 1023–1030. 49 indexed citations
14.
Prebisch, Raúl, et al.. (2011). O manifesto latino-americano : e outros ensaios. Medical Entomology and Zoology. 13 indexed citations
15.
Hatchell, Esme C., Shane M. Colley, Dianne J. Beveridge, et al.. (2006). SLIRP, a Small SRA Binding Protein, Is a Nuclear Receptor Corepressor. Molecular Cell. 22(5). 657–668. 102 indexed citations
16.
Haase‐Pettingell, Cameron, Scott D. Betts, Stephen W. Raso, et al.. (2001). Role for cysteine residues in the in vivo folding and assembly of the phage P22 tailspike. Protein Science. 10(2). 397–410. 25 indexed citations
17.
Gordon, Andrew S., et al.. (2000). Dissolved copper-complexing ligands in cultures of marine bacteria and estuarine water. Marine Chemistry. 70(1-3). 149–160. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026